June 1, 2014

White paper: Securing the Global Pharmaceutical Supply Chain against the Threat of Counterfeit Drugs

By Ruediger Lomb

The scope and prevention of counterfeit drugs
Topics:
Quality Commercial supply chain

About The Author

Portrait of Ruediger Lomb
Ruediger Lomb
Vice President, Enterprise Quality Assurance, International Operations
AmerisourceBergen Global Commercialization Services & Animal Health
View Bio

Related Content

Webinar on-demand: La vérification des flux logistiques, un enjeu de taille

Inverted color AmerisourceBergen icon
World Courier
June 2020
cell and gene therapy shipping

Executive Summary: Logistics by Design - a Framework for Advanced Therapy Developers to Create Optimal Logistics Platforms

Inverted color AmerisourceBergen icon
World Courier
January 2019

Logistics by Design (LbD) is a framework for logistics decision making. Using a risk based analysis it identifies the areas within the supply chain that need to be addressed to create a logistics platform that can meet the needs of patients at clinical and commercial scale.

White paper: How to mitigate risk and create competitive advantage with a new model of pharmaceutical logistics

A portrait of Christopher Engel.
Christopher Engel
World Courier
April 2018

Find out how to create competitive advantage by developing a fit-for-purpose supply chain that supports the market’s paradigm shift.

  • Terms and conditions
  • Privacy statement
  • Cookies policy
  • Data subject request
  • Conditions of carriage
  • Fraud alert notice
  • Modern slavery act
  • Facebook
  • LinkedIn
  • X
Contact sales
Cencora logo

brand="Cencora" culture="EN" env="Development" tracker="False"